Photo by Innerbody Research Around 30-50% of American adults dont get enough sleep.1 The consequences of this insufficiency can be steep, as without a regular 7-8 hours rest per night, a person can find themselves at risk for depression, decreased cognitive function, and an increased risk of cardiovascular and endocrine dysfunction.2 For the many millions of people with sleep deficiency, a peptide called DSIP could be a solution, although some researchers might disagree
This ratio is an important component of what is called the redox state of a cell, a measurement that reflects both the metabolic activities and the health of cells
Wegovy slows gastric emptying through GLP-1 receptor activation, which increases satiety but also slows digestive transit time
While BPC-157 and some other peptides show promise, thus far they lack robust human clinical evidence for the conditions they're marketed to treat
Association of C677T polymorphism (Rs1801133) in MTHFR gene with depression
Pro-inflammatory cytokines influence neurotransmitters such as serotonin and dopamine Microglial activation and bloodbrain barrier dysfunction contribute to neuronal injury Provides insight into treatment resistance and symptom variability This evolving paradigm reinforces that psychiatric disorders are not purely psychological but involve complex neuroimmune interactionsopening pathways for future targeted therapies